Evidence map›Paper›PMID 41190812›Full record

ArticleJournal of virology2025

N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages.

Caroline K Page, M H M Mubassir, Pradeep Chopra, Lindsey Claire Gay, Ginger Geiger, Sean D Ray, Justin D Shepard, Rose J Miller, Daniel Perez, Justin Bahl and 2 more

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Caroline K Page *Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.ORCID 0009-0003-7987-9563
M H M Mubassir *Center for Influenza Disease and Emergence Response (CIDER), University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-9674-2425
Pradeep ChopraCenter for Influenza Disease and Emergence Response (CIDER), University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-6003-4574
Lindsey Claire GayCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
Ginger GeigerCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
Sean D RayCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
Justin D ShepardCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
Rose J MillerCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
Daniel PerezCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-6569-5689
Justin BahlCenter for Influenza Disease and Emergence Response (CIDER), University of Georgia, Athens, Georgia, USA.ORCID 0000-0001-7572-4300
Gerardus Josephus BoonsCenter for Influenza Disease and Emergence Response (CIDER), University of Georgia, Athens, Georgia, USA.ORCID 0000-0003-3111-5954
Stephen Mark TompkinsCenter for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-1523-5588

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00018 · NIAID · UNIVERSITY OF GEORGIA · PI TOMPKINS, S. MARK · 2021 to 2025
$21.6M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Role of spatial structure in shaping viral population diversity and evolutionR01AI154894 · NIAID · EMORY UNIVERSITY · PI KOELLE, KATHARINA V, LOWEN, ANICE C · 2020 to 2024
$2.8M
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactionsR01AI165692 · NIAID · UNIVERSITY OF GEORGIA · PI BOONS, GEERT-JAN · 2022 to 2025
$2.2M
NIAID NIH HHS 75N93021C00014NIAID NIH HHS 75N93021C00018NIAID NIH HHS HHSN266200700010CNIAID NIH HHS R01 AI154894NIAID NIH HHS R01 AI165692NIAID NIH HHS T32 AI007647NIH HHS HHSN272201400008C
6 · The paper itself

Abstract

Receptor specificity plays a critical role in influenza virus host tropism and pathogenesis. Influenza A and influenza B viruses (FLUAVs and FLUBVs, respectively) utilize N-glycans with terminal sialic acids on glycoproteins decorating the surface of mucosal epithelial cells as receptors for the virus hemagglutinin (HA) protein. For FLUAVs, the specificity of HA binding to distinct sialic acid linkages on host glycans is a major determinant of species specificity. Amino acid motifs and N-linked glycosylation sites influencing FLUAV HA receptor specificity are well defined. In contrast, considerably less is known regarding determinants of FLUBV receptor specificity, despite its significant contribution to the global influenza disease burden and unique restriction for human hosts. To address this knowledge gap, we utilize microarrays populated with glycans resembling structures found in the respiratory tract to comprehensively define the receptor binding profiles of FLUBVs from different decades and lineages and confirm these results with complementary virus-glycan binding assays. Using wild-type and reverse genetics FLUBVs having singular mutations in the HA receptor binding site (RBS), as well as structural models, we identify an N-glycosylation site at amino acid 196 within the RBS that determines the breadth of HA binding to terminal sialic acids. The definition of the presence of an N-linked glycan as the primary determinant for FLUBV receptor specificity provides a clear mechanism for lineage-specific differences in HA receptor binding. This may help explain the distinct tropism observed between Victoria and Yamagata lineage FLUBVs and provide insights into the disappearance of the Yamagata lineage.IMPORTANCEInfluenza B viruses (FLUBVs) are a major cause of human respiratory disease, but the molecular determinants influencing receptor specificity for the hemagglutinin protein remain largely undefined. We defined the receptor specificity of a panel of Early, Victoria, and Yamagata lineage viruses spanning over 50 years and showed that Victoria lineage viruses can have expanded receptor specificity, compared to Yamagata lineage viruses. We identified a critical N-glycosylation site within the hemagglutinin that regulates hemagglutinin binding to sialic acid receptors on host cells. Recent successful subclades of the Victoria lineage viruses lost this glycosylation site, enabling binding to both human-type and avian-type sialic acid receptors, which may influence respiratory tract tropism. These viruses also showed increased endemic activity. The expanded receptor tropism of Victoria lineage viruses may have fitness benefits, helping to explain epidemiologic features of the lineage, perhaps contributing to the lineage's recent success, while the Yamagata lineage appears to have become extinct.

Indexed as

Hemagglutinin Glycoproteins, Influenza VirusInfluenza B virusReceptors, VirusAnimalsBinding SitesDogsGlycosylationHumansInfluenza A virusInfluenza, HumanMadin Darby Canine Kidney CellsPolysaccharidesProtein BindingViral TropismVirus AttachmentHemagglutinin Glycoproteins, Influenza VirusPolysaccharidesReceptors, VirusFLUBVglycosylationinfluenzareceptor specificityVictoriaYamagata

Identifiers

PMID41190812
PMCPMC12645935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.